June 16, 2026 - EverGlade

June 16, 2026

ARPA-H Launches REST to Transform Sleep Through Home-Based Sleep Diagnostics and Treatment

Leave a Comment / All Posts, ARPA-H, Life Sciences / By

Download the Solicitation Why ARPA-H is Seeking Solutions for Sleep Health The Advanced Research Projects Agency for Health (ARPA-H), through its Proactive Health Office (PHO), has released an Innovative Solutions Opening (ISO) for the Restorative and health-Enhancing Sleep Time (REST) program (ARPA-H-SOL-26-159). REST seeks to fundamentally change how sleep quality is measured, diagnosed, and treated by

ARPA-H Launches REST to Transform Sleep Through Home-Based Sleep Diagnostics and Treatment Read More »

BARDA Seeks Input on Next-Generation High-Performance Antigen Diagnostics

Leave a Comment / All Posts, BARDA, Life Sciences / By

Download the Solicitation Overview of the RFI The Biomedical Advanced Research and Development Authority (BARDA), through the Rapid Response Partnership Vehicle (RRPV), has released a Request for Information (RFI) titled “High Performance Antigen Diagnostics.” Through this market research effort, BARDA is seeking feedback from industry, academia, and other stakeholders to better understand the landscape of current and emerging high-performance immunoassay

BARDA Seeks Input on Next-Generation High-Performance Antigen Diagnostics Read More »

BARDA Issues RFP Under Project BioShield for 2-PAM Autoinjectors to Strengthen Chemical Threat Preparedness 

Leave a Comment / All Posts, BARDA, Defense, Life Sciences / By

Download the Solicitation The Biomedical Advanced Research and Development Authority (BARDA), within the Administration for Strategic Preparedness and Response (ASPR), has released a Request for Proposals (RFP) for 2-PAM Autoinjectors for Project BioShield. The RFP supports late-stage clinical development, regulatory approval, procurement, and delivery of pralidoxime, also known as 2-PAM, autoinjectors for the treatment of organophosphate (OP)

BARDA Issues RFP Under Project BioShield for 2-PAM Autoinjectors to Strengthen Chemical Threat Preparedness  Read More »

Scroll to Top